SCHEMBL9029993

SCHEMBL9029993

CCOC(=O)c1ccc(CCN)c(C)c1C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
TSHR P16473 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 3/20 0.41
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA7 P43166 3/20 0.40
CA9 Q16790 3/20 0.40
CA14 Q9ULX7 3/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAOA P21397 1/20 0.40
HTR6 P50406 1/20 0.38
PKM P14618 1/20 0.37
ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718232 0.80 ALDH1A1 (0.53) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL7443982 0.78 TSHR (0.49) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL24717740 0.77 TSHR (0.47) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL7438131 0.75 KDM4E (0.43) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL4626796 0.73 METAP2 (0.46) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL26126976 0.73 TSHR (0.50) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL6600799 0.73 TSHR (0.65) KDM4ETSHRALDH1A1HSD17B10LMNA
SCHEMBL11296630 0.72 TSHR (0.63) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL28161602 0.71 TSHR (0.65) KDM4ETSHRALDH1A1HSD17B10CA12
SCHEMBL301812 0.71 TSHR (0.55) KDM4ETSHRALDH1A1HSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0741715-A1 NOVEL HUMAN LEUKOCYTE ELASTASE (HLE) INHIBITORS, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SRI INTERNATIONAL (US) 1996-11-13 EP disclosed